Navigation Links
Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc.
Date:6/5/2008

Amended Master Purchase Contract Provides for the Sale of Ready to Drink Suite of Nutritional Supplements to Provider Services, Inc. to be Increased

Annually by $3.4M or 142%

BASKING RIDGE, N.J., June 5 /PRNewswire/ -- Millennium Biotechnologies Inc., wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) announced today that it has entered into an amendment of it's November 9th 2007 Master Purchase Contract with Provider Services, Inc. ("PSI") to increase their quarterly purchase commitment from Six Hundred Thousand Dollars ($600,000) to One Million Four Hundred and Fifty Thousand Dollars ($1,450,000) effective July 1 2008. This quarterly increase currently translates into an annualized commitment of Five Million Eight Hundred Thousand Dollars ($5,800,000). Before year end, Millennium intends to expand its Long Term Care product line by launching additional products, including a tube feeding product as well as products designed and developed for the diabetic population.

"I am extremely proud of our team and our ability to design, develop, test and bring to market our ready to drink Resurgex Essential and Resurgex Essential Plus products which have been so well received by PSI. These strictly kosher products made under the most stringent rabbinical supervision will be marketed to a rapidly expanding global population in Long Term Care. As a billion dollar marketing opportunity, we believe that these products and their tube feeding and diabetic line extensions will provide an exceptional revenue growth opportunity for Millennium," stated Mark C. Mirken, President and COO of Millennium.

"The availability of the Resurgex Essential and the Essential Plus product line in a ready to drink format in three incredible flavor profiles has drastically increased the utilization of all nutritional products throughout our facilities which service 5,000 beds. Our residents are, for the first
'/>"/>

SOURCE Millennium Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
2. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
3. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
4. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
5. Life Sciences Leader Joins Millennium Board of Directors
6. Millennium to Webcast Third-Quarter 2007 Financial and Operational Results
7. Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
8. Millennium Research Group Offers New Marketrack Service that Tracks European Dental Implant Market
9. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
10. Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order
11. Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014  Cannabis Science, Inc. (OTC: CBIS), ... development and related consulting, applauds the Editorial Board ... strong position in opposition to current federal law ... publication.  The New York Times also announces a ... exploring the issue called "High Time:  An Editorial ...
(Date:7/29/2014)... Philadelphia, PA (PRWEB) July 29, 2014 Philadelphia’s ... to help businesses get their start. The Innovation Center ... and the University City Science Center to help ... its doors on Monday, July 28. , ... corner of 34th and Market Streets, is the new home ...
(Date:7/29/2014)... 2014 Quorum Review IRB, the ... awarded accreditation by the International Association of ... Six Sigma Deployment Program. The citation recognizes robust ... , Quorum’s Lean Six Sigma program was evaluated ... designation. The designation is a public statement of ...
(Date:7/29/2014)... San Diego, CA (PRWEB) July 29, 2014 ... added to Pipette.com’s centrifugation product selection. Eppendorf 5427 R ... reverse engineering, and DNA – it is targeted towards ... the Eppendorf Centrifuge 5427 R as it compliments their ... as their Eppendorf line of microcentrifuge tubes, PCR tubes, ...
Breaking Biology Technology:Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 3Innovation Center @3401 Opens for Business; DreamIt Ventures and Point.io First Residents 2Innovation Center @3401 Opens for Business; DreamIt Ventures and Point.io First Residents 3Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 2Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 3International Pipette Distributor, Pipette.com Announces the Addition of the Eppendorf Centrifuge 5427 R to Their Product Portfolio 2
... Nov. 1 Elbit Medical,Imaging Ltd. (Nasdaq: EMITF ... Meeting of its shareholders held today, Thursday, November,1, 2007, ... set forth in EMI,s proxy statement dated,September 6, 2007 ... approved by the required majorities, except that the,following proposals ...
... 1 Proteon Therapeutics,( http://www.proteontherapeutics.com ), a ... to address the,medical needs of patients with ... the Annual Meeting of the American Society ... (PRT-201) Dilates Outflow,Veins in a Preclinical Model ...
... free home caregiving to disabled veterans, DENVER, ... We Care For Veterans campaign to honor the ... disabled veterans. (Logo: http://www.newscom.com/cgi-bin/prnh/20070521/LAM004ALOGO ) ... 20 hours each of free in-home care services ...
Cached Biology Technology:Elbit Medical Imaging Ltd. Announces Results of Its Annual General Meeting 2Elbit Medical Imaging Ltd. Announces Results of Its Annual General Meeting 3Proteon Therapeutics to Present at Annual Meeting of American Society of Nephrology in San Francisco on November 2, 2007 2Homewatch CareGivers Launches 2007 We Care For Veterans Campaign 2
(Date:7/28/2014)... approved by the U.S. Food and Drug Administration (FDA) ... certain bacterial pathogens inside human cells, including those that ... findings, published in mBio , the online open-access ... new way of identifying non-antibiotic drugs that could one ... of drugs on the list inhibit the growth of ...
(Date:7/28/2014)... a circulatory problem of the legs called peripheral vascular ... surgery in serious cases. This disease can lead to ... , At The University of Texas Health Science Center ... preventative treatment in a mouse model of the disease ... Their proof-of-concept study appears in the journal Cell ...
(Date:7/28/2014)... suggests that the effects of a commonly used anesthetic ... , The study, published in this week,s issue of ... biologists at the University of California, San Diego and ... to concerns, arising from multiple studies on humans over ... may increase their susceptibility to long-term cognitive and behavioral ...
Breaking Biology News(10 mins):New route to identify drugs that can fight bacterial infections 2Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3
... Since Moffat and Ramsden for the first time discovered ... 1977, over the last two decades, great progress has ... Jrgensen and Mathiesen were the first authors to note ... in adult Australian parrots. Later, Roberson et al studied ...
...  DiscoveRx Corporation, through its BioSeek division, today announced ... assay platform for oncology research. Consisting of primary ... panel enables researchers to easily assess the phenotypic ... to better predict in vivo drug ...
... plants, the growth of organs such as roots, leaves ... reservoir-like compartments hold stem cells, which have the ability ... At Cold Spring Harbor Laboratory (CSHL), Professor David ... insights about how plants regulate their growth. This work ...
Cached Biology News:DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research 2DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research 3In odd-looking mutant, clues about how maize plants control stem cell number 2
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
... ICE-family proteases/caspases initiates apoptosis in mammalian cells. ... Kit provides a simple and convenient means ... cytometry in intact cells. The assay ... residues linked to rhodamine 110 (D2R), a ...
The PROTEAN II slab gel casting stand is a component of the PROTEAN II XL and xi casting apparatus. It is supplied with gaskets....
Biology Products: